NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has priced its $1.3 billion offering of senior notes, the firm announced after the close of the market yesterday.

It is offering $500 million of 1.85 percent senior notes due 2018, and $800 million of 3.15 percent notes due 2023. The firm expects to close the offering on Aug. 22.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.